Skip to content

Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation

Hypertensive Phase and Its Association with Surgical Failure in Baerveldt Implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20141127002
Enrollment
Unknown
Registered
2014-11-27
Start date
2013-12-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rate of hypertensive phase and its association with surgical failure Hypertensive Phase Baerveldt implantation

Interventions

Glaucoma patients&#44
age > 20 years&#44
with indication for Baerveldt implant&#44
operated in King Chulalongkorn Memorial Hospital since 2004&#45
2014.
Treatment
Baerveldt implantation patients

Sponsors

Faculty of Medicine Chulalongkorn University
Lead Sponsor
King Chulalongkorn Memorial Hospital
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: • Glaucoma patients age ≥20 yrs who need surgical treatment by Baerveldt implantation • Baerveldt implantation by glaucoma specialist in King Chulalongkorn Memorial Hospital since 2004 to present and follow up >=18 months

Exclusion criteria

Exclusion criteria: • Glaucoma patients operated by Baerveldt combined with other procedure such as Trabeculectomy with antimetabolites • Patient F/U less than 18 months

Design outcomes

Primary

MeasureTime frame
Rate of hypertensive phase 18 months Percent

Secondary

MeasureTime frame
Surgical failure 18 months Percent

Contacts

Public ContactDepartment of Ophthalmology Chulalongkorn university

Chulalongkorn university

tammapat@gmail.com022564142

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026